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Changes in plasma C1q, apelin
and adropin concentrations
in older adults after descending
and ascending stair walking
intervention
Trevor C. Chen 1*, Tsang‑Hai Huang 2, Wei‑Chin Tseng3, Kuo‑Wei Tseng3,
Chung‑Chan Hsieh1, Mei‑Yen Chen 4, Tai‑Ying Chou5, Yuh‑Chuan Huang6, Hsin‑Lian Chen7 &
Kazunori Nosaka 8
This study compared changes in plasma complement component 1q (C1q), apelin and adropin
concentrations in older obese women after descending (DSW) and ascending stair walking (ASW)
training (n = 15/group) performed twice a week for 12 weeks, with gradual increases in exercise time
from 5 to 60 min. Fasting blood samples were collected 3 days before the first and 4 days after the last
training session. The improvements in the maximal voluntary isometric contraction (MVIC) strength
of the knee extensors, functional physical fitness [e.g., 30-s chair stand (CS) performance], resting
systolic blood pressure (SBP), insulin sensitivity [e.g., oral glucose tolerance test (OGTT)] and blood
lipid profiles [e.g., total cholesterol (TC)] were greater (p < 0.05) in the DSW than ASW group. Plasma
C1q decreased (− 51 ± 30%), and apelin (23 ± 15%) and adropin (127 ± 106%) increased (p ≤ .0.05)
only after DSW. Significant (p ≤ 0.01) partial correlations were found between the pre- to post-DSW
changes in C1q, apelin or adropin and changes in outcome measures [e.g., C1q and MVIC (r = − 0.837),
apelin and SBP (r = − 0.854), and andropin and OGTT (r = − 0.729)]. These results showed that greater
decreases in plasma C1q and greater increases in apelin and adropin concentrations were associated
with greater improvements in outcome measures after DSW than after ASW.
It is recommended that individuals engage in 150 to 300 min of moderate intensity physical activity, 75 to 150 min
of vigorous-intensity physical activity, or an equivalent combination of both moderate and vigorous activities
each week and muscle strengthening activities at least two days each week1,2. However, only 22% of adults meet
these recommendations, and the number decreases with increasing a ge3. Physical inactivity is a cause of many
chronic diseases4, and regular exercise is key for increasing health span, quality of life and well-being5. Thus,
exercises that more efficient and effective in achieving these outcomes should be implemented, and it appears
that muscle contraction type is a factor affecting these outcomes.
A previous study showed that resistance training emphasising eccentric (lengthening) contractions of the
knee extensors once a week for 12 weeks increased knee extension muscle strength, functional physical fitness
such as the ability to stand up and sit down in a chair as quickly as possible for 30 s, insulin sensitivity and blood
lipid profiles in older men greater than training emphasising concentric (shortening) c ontractions6. Another
study found that descending stair walking (DSW), in which the knee extensors predominantly undergo eccentric
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contractions, twice a week for 12 weeks was also more effective in improving muscle strength, functional physical
fitness, blood pressure, insulin sensitivity and blood lipid profiles in older obese women than ascending stair
walking (ASW), in which the knee extensors mainly undergo concentric c ontractions7. However, it is not known
why exercise training involving eccentric contractions (i.e., eccentric training) produces greater adaptations of
not only the muscles that are stimulated during the training but also other organs in the body to improve blood
pressure, insulin sensitivity and blood lipid profiles6,8. It may be that changes in some biomarkers induced by
exercise training involving eccentric contractions (e.g., DSW) and that involving concentric contractions (e.g.,
ASW) are different.
Some studies have shown that the expression of complement component 1q (C1q), which is a protein complex
involved in the innate immune s ystem9, increases with age and leads to muscle fibrosis and a trophy10,11. Previous studies12,13 have reported that C1q expression in the blood is a marker of sarcopenia and that the higher the
concentration of C1q is in the blood, the greater the extent of sarcopenia. Watanabe et al.13 reported that 12 weeks
of resistance training of the knee flexors and extensors three times a week with a load of 70% one-repetition
maximal (1-RM) consisting of 3 sets of 10 repetitions per session decreased the serum C1q concentration by 39%,
and increased maximal voluntary isometric contraction (MVIC) strength by 8–12% and muscle cross-sectional
area by 7% in older adults. Thus, it may be that eccentric exercise training decreases the C1q concentration in
the blood more than concentric exercise training.
Apelin is produced and secreted by adipose t issue14 and affects various physiological processes, including
modulating cardiovascular function and glucose homeostasis, promoting insulin sensitivity and modulating
energy metabolism, lipogenesis and lipolysis15. Kadoglou and colleagues16 found significant increases in the
serum apelin concentration (+ 39%) after 12 weeks of aerobic exercise training in patients with type 2 diabetes
mellitus (T2DM). Afshounpour and c olleagues17 also showed that the plasma apelin concentration increased by
29% and that this increase was accompanied by improved insulin resistance after 8 weeks of aerobic and wholebody resistance exercise training in patients with T2DM. It is possible that eccentric exercise training increases
the apelin concentration in the blood more than concentric exercise training.
Adropin is known as a regulator of endothelial nitric oxide (NO) synthase and NO release, and the circulating
adropin concentration decreases with age18,19. Fujie and colleagues19 reported that the serum adropin concentration increased by 80% in middle-aged and older individuals after 8 weeks of aerobic cycling training three times
per week and that the increase in the serum adropin concentration was significantly correlated with a decrease
in carotid beta-stiffness and an increase in the plasma NO concentration. It might be that changes in the adropin
concentration in the blood are greater after eccentric exercise training than concentric exercise training.
As mentioned above, we found that knee extensor MVIC strength (34%) and physical function (8–42%) were
increased, systolic blood pressure (SBP) was decreased by 9%, and insulin sensitivity [e.g., oral glucose tolerance
test (OGTT) results: − 12%] and lipid profiles [e.g., low-density lipoprotein cholesterol (LDLC) level: − 13%] were
improved in elderly obese women who performed DSW twice a week for 12 weeks with a progressive increase
in repetitions from two (110 steps × 2 = 220 steps) to 24 (110 steps × 24 = 2,640 steps) compared with those who
performed ASW (15%, 4–22%, − 2% and − 7%, respectively)7. We hypothesised that the plasma C1q concentration would decrease to a greater extent and that apelin and adropin concentrations would increase to a greater
extent after DSW training than after ASW training. To test this hypothesis, we used the stored blood samples
from our previous s tudy7 to measure C1q, apelin and adropin concentrations in stored plasma samples taken at
baseline and after the 12-week DSW and ASW i nterventions7, compared the changes in concentrations between
the DSW and ASW groups, and investigated the relationships between the changes in the blood markers and the
changes in musculoskeletal parameters, functional physical fitness, cardiovascular function (resting heart rate
(HR) and blood pressure), insulin sensitivity and lipid profiles, which had been evaluated in our previous s tudy7.

Results

Baseline measurements. No significant (p > 0.05) differences in any of the outcome measures (Tables 1,
2) or for plasma C1q, apelin and adropin concentrations were found between the DSW and ASW groups (Fig. 1)
at the baseline.

Changes in outcome measures.

Significant differences in the changes in resting heart rate (HR) and
SBP were found between the DSW and ASW groups, with the DSW group showing a greater decrease than
the ASW group (HR: interaction effect: p = 0.003, η2 = 0.480; SBP: p = 0.018, η2 = 0.341; Table 1). Significantly
(p ≤ 0.05) greater improvements in the MVIC strength of the knee extensors (p < 0.001, η2 = 0.653), upper thigh
circumference (CIR; p = 0.024, η2 = 0.313), and calcaneal bone mineral density (BMD) of the right heel (p = 0.002,
η2 = 0.499) were also evident after DSW training than after ASW training (Table 1). Significant (p ≤ 0.05) improvements in performance in all functional physical fitness tests were observed in both the DSW and ASW groups
following the 12-week training, but the magnitude of the improvements in performance in the 30-s chair stand
(CS) test p = 0.007, η2 = 0.420), balance with eyes closed on an unstable surface (ECUS; p < 0.001, η2 = 0.742) and
balance with eyes open on a firm surface (EOFS; p < 0.001, η2 = 0.585) was greater (p ≤ 0.05) after DSW training
than after ASW training, as shown in Table 1. As shown in Table 2, significantly (p ≤ 0.05) greater changes in
all insulin sensitivity (e.g., glucose concentration: p = 0.042, η2 = 0.263) and lipid profile (e.g., triglyceride (TG)
concentration: p = 0.013, η2 = 0.365) parameters were found after DSW training than after ASW training.

Changes in plasma C1q, apelin, and adropin concentrations. After 12-week DSW training, the

plasma C1q concentration decreased [p < 0.001, eta-squared values (η2) = 0.599], and the apelin (p < 0.001,
η2 = 0.767) and adropin (p = 0.003, η2 = 0.480) concentrations increased, but no significant changes were found
after ASW training (C1q concentration: p = 0.885, η2 = 0.002; apelin concentration: p = 0.267, η2 = 0.087; adropin
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Group
Body mass (kg)
HR (beats/min)
MVIC (N)
6 MW (m)
ECUS (SI)

ASW
DSW
ASW
DSW
ASW
DSW

Pre

Post

Group

62.7 ± 6.4

62.1 ± 5.9#

62.8 ± 5.1

#

80.3 ± 4.7
79.2 ± 4.5
245.3 ± 29.4
262.4 ± 25.5

BMI (kg/m2)

61.7 ± 5.2
77.1 ± 5.1

#
#,

71.5 ± 6.2 *
#

280.5 ± 27.3

#,

352.2 ± 55.7 *
#

ASW

467.0 ± 38.9

482.6 ± 34.2

DSW

460.1 ± 31.3

496.1 ± 41.6#

ASW

2.86 ± 0.20

2.72 ± 0.31#

DSW

2.88 ± 0.25

2.08 ± 0.43#,*

SBP (mmHg)
CS (times)
TW (s)
CIR (cm)

Pre

ASW
DSW
ASW
DSW

Post
25.8 ± 0.7#

26.2 ± 1.1

#

122.6 ± 11.7
119.9 ± 9.3

ASW
DSW

Group

26.1 ± 0.8

Body fat (%)

25.7 ± 1.1

118.5 ± 12.4

#
#,

109.7 ± 10.8 *

16.5 ± 1.4
15.0 ± 1.3

19.9 ± 1.6

#
#,

21.3 ± 3.5 *
#

ASW

27.1 ± 4.2

24.0 ± 2.7

DSW

26.3 ± 4.0

21.6 ± 4.7#

ASW

48.1 ± 3.7

48.4 ± 3.6#

DSW

48.6 ± 2.6

49.2 ± 2.5#

DBP (mmHg)
2MS (times)
EOFS (SI)
BMD (m/s)

Pre

Post

ASW

34.6 ± 5.3

33.4 ± 4.8#

DSW

36.4 ± 3.3

35.1 ± 3.4#

ASW

69.3 ± 7.7

65.6 ± 7.5#

DSW

69.1 ± 7.2

64.1 ± 7.1#

ASW

111.0 ± 5.1

118.9 ± 6.0#

DSW

110.1 ± 4.7

122.2 ± 14.5#

ASW

0.69 ± 0.06

0.64 ± 0.07#

DSW

0.68 ± 0.05

0.52 ± 0.09#,*

ASW

1492.3 ± 66.3

1496.8 ± 36.1

DSW

1487.5 ± 55.3

1576.9 ± 69.7#,*

Table 1.  Changes (mean ± SD) between the pre- and post-training time points in the ascending (ASW; n = 15)
and descending stair walking (DSW; n = 15) groups for body mass, body mass index (BMI), percent body
fat, resting heart rate (HR), systolic (SBP) and diastolic blood pressure (DBP), maximal voluntary isometric
contraction strength of the knee extensors (MVIC), performance in the 30-s chair stand (CS), 2-min step
(2MS), 6-m walk (6 MW), 6-m tendon walk (TW) test, balance with eyes open on firm surface (EOFS),
balance with eyes closed on unstable surface (ECUS), upper thigh circumference (CIR), and bone mineral
density (BMD). # : significant (p ≤ 0.05) difference compared with the pre-training level. *: significant (p ≤ 0.05)
difference compared with the ASW group.

GLU (mg/dL)
HbA1c (%)
TC (md/dL)

Group

pre

post

Group

ASW

111.5 ± 6.9

106.4 ± 6.6#

ASW

83.3 ± 6.9

79.1 ± 5.6#

DSW

113.9 ± 15.5

104.2 ± 18.4#,*

DSW

85.4 ± 7.1

69.2 ± 5.3#,*

ASW

5.86 ± 0.35

5.88 ± 0.65

ASW

816.4 ± 69.6

798.6 ± 86.1#

DSW

5.87 ± 0.27

5.58 ± 0.38#,*

DSW

833.7 ± 61.8

733.6 ± 80.5#,*

ASW

208.5 ± 18.5

201.1 ± 14.8#

ASW

125.9 ± 12.5

116.0 ± 7.9#

DSW

215.2 ± 20.3

194.5 ± 24.9#

DSW

127.5 ± 11.9

110.5 ± 13.3#,*

INS (pmol/L)
OGTT (mg/dL/2 h)
LDLC (md/dL)

pre

post

Group
HOMA (A.U.)
TG (md/dL)
HDLC (md/dL)

ASW
DSW

pre

post

2.64 ± 0.32 2.39 ± 0.24#
2.74 ± 0.32 2.02 ± 0.28#,*

ASW

105.9 ± 8.6

97.9 ± 11.3#

DSW

109.3 ± 8.4

88.1 ± 19.6#,*

ASW

64.4 ± 6.1

64.2 ± 5.9

DSW

62.1 ± 5.7

68.3 ± 7.4#,*

Table 2.  Changes (mean ± SD) in resting glucose (GLU) and insulin (INS) concentrations, the homeostasis
model assessment (HOMA) index, whole blood glycosylated hemoglobin (HbA1c) concentration, oral glucose
tolerance test (OGTT) results, total cholesterol (TC), triacylglycerol (TG), low- (LDLC) and high-density
lipoprotein cholesterols (HDLC) concentrations before (pre) and after (post) ascending (ASW; n = 15) and
descending stair walking (DSW; n = 15). # : significant (p ≤ 0.05) difference compared with the pre-training level.
*: significant (p ≤ 0.05) difference compared with the ASW group.

Figure 1.  Changes (individuals, mean ± SD) in plasma complement component 1q (C1q) (a), apelin (b) and
adropin (c) concentrations before (pre) and after (post) 12 weeks of descending (DSW) and ascending stair
walking (ASW) interventions. *Significant change (p ≤ 0.05) compared to the baseline (pre) level in each group;
ns: no significant difference (p ≥ 0.05) from the baseline (pre) level; #Significant difference (p ≤ 0.05) compared to
the post-intervention level in the ASW group.
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HR
C1q
Apelin
Adropin

MVIC

CS

2MS

r

.446

.614

.355

− .837*

− .608

− .391

p

.098

.029

.157

.001

.031

.132

r

− .573

− .854*

− .783*

.565

.594

.211

p

.042

.001

.004

.044

.035

.279

r

− .122

− .348

− .044

.413

.378

.216

p

.368

.162

.452

.118

.141

.275

GLU
C1q
Apelin
Adropin

SBP

EOFS

ECUS

− .873* − .233

.703

.523

− .825*

− .929*

< .001

.259

.012

.061

.002

< .001

.750*

.279

− .407

− .696

.397

.591

.006

.217

.122

.013

.128

.036

.399

.025

− .736*

.127

.472

.008

HOMA

HbA1c

OGTT

LDLC

HDLC

.322

.416

.391

.447

.035

.417

.179

− .630

p

.174

.182

.116

.132

.097

.462

.115

.310

.025

r

− .185

− − .483

− .406

− .360

− .426

− .316

− .446

− .119

.590

.304
− .723*

p

.009

.079
− .447
.098

.122
− .713*
.010

.153
− .471
.085

.110
− .729*
.008

.187
− .493
.074

TC

TW

.332

p

TG

6 MW

r

r

INS

DBP

.098
− .863*
.001

.371
− .672
.017

CIR

BMD

− .578

.435

.526

.040

.104

.059

.036
.873*
< .001

Table 3.  Multiple partial correlations (partial r and p values) between the normalised changes in plasma
complement component 1q (C1q), apelin and adropin concentrations between before and after 12 weeks
of descending stair walking (DSW) training and the normalised changes in resting heart rate (HR), systolic
(SBP) and diastolic blood pressure (DBP), the maximal voluntary isometric contraction strength of the knee
extensors (MVIC), 30-s chair-stand (CS), 2-min step (2MS), 6-m walk (6 MW), 6-m tendon walk (TW) test
performance, balance with eyes open on firm surface (EOFS) and eyes closed on unstable surface (ECUS),
upper thigh circumference (CIR), and bone mineral density (BMD) [upper table], and resting glucose (GLU)
and insulin (INS) levels, the homeostasis model assessment (HOMA) index, whole blood glycosylated
hemoglobin (HbA1c) concentration, oral glucose tolerance test (OGTT) results, total cholesterol (TC)
concentration, triacylglycerol (TG) concentration, low- (LDLC) and high-density lipoprotein cholesterols
(HDLC) concentrations [lower table] in the participants in the descending stair walking (DSW) group (n = 15).
*: significant (p ≤ 0.01) correlation.

concentration: p = 0.165, η2 = 0.133) (Fig. 1). The magnitude of the decrease in C1q concentration (p < 0.001,
η2 < 0.600) and the increase in apelin (p = 0.011, η2 = 0.378) and adropin (p = 0.014, η2 = 0.361) concentrations
between the pre- to post-training time points was greater in the DSW group than in the ASW group (Fig. 1).

Correlations between changes in C1q, apelin or adropin concentrations and changes in out‑
come measures. Table 3 shows the results of partial correlation analyses of the magnitude of changes in
plasma C1q, apelin, and adropin concentrations and the changes in HR, blood pressure, muscle strength, functional physical fitness, muscle and bone, insulin sensitivity, and lipid profile parameters from baseline to the
post-training time point for participants in the DSW group. The normalised change in C1q concentration was
significantly (p ≤ 0.01) correlated with the changes in MVIC (Fig. 2a), upper thigh circumference (Fig. 2b), 6-m
walk (6 MW) test results and calcaneal BMD between the pre- to post-training time point in the DSW group.
The normalised change in apelin concentration was significantly (p ≤ 0.01) correlated with the changes in SBP
(Fig. 2c), diastolic blood pressure (DBP) (Fig. 2d) and 6 MW test results between pre- to post-training time
points in the DSW group. The normalised change in adropin concentration was also significantly (p ≤ 0.01)
correlated with the changes in balance with EOFS, serum glucose concentration, homeostasis model assessment (HOMA) index, OGTT results (Fig. 2e), total cholesterol (TC) concentration and high-density lipoprotein
cholesterol (HDLC) concentration (Fig. 2f). In the ASW group, a significant (p ≤ 0.01) correlation was between
changes in the apelin concentration and changes in DBP (r = − 0.732, p = 0.008), between changes in the apelin
concentration and changes in CS (r = − 0.717, p = 0.010), and between changes in the apelin concentration and
changes in glycosylated haemoglobin (HbA1c) concentration (r = 0.762, p = 0.005) only.

Discussion

The main findings of the present study were that (1) changes in plasma C1q, apelin and adropin contractions were
greater after DSW training than after ASW training (Fig. 1); (2) the magnitude of decrease in the plasma C1q concentration after DSW was significantly correlated with the changes in the upper thigh circumference (r = − 0.825,
p = 0.002), BMD (r = − 0.929, p < 0.001), MVIC strength (r = − 0.837, p = 0.001) and 6 MW test results (r = − 0.873,
p < 0.001); 3) the magnitude of increase in the plasma apelin concentration after DSW was significantly correlated
with the changes in SBP (r = − 0.854, p = 0.001), DBP (r = − 0.783, p = 0.004) and 6 MW test results (r = 0.750,
p = 0.006); and 4) the magnitude of changes in the plasma adropin concentration after DSW was significantly
correlated with balance with EOFS (r = − 0.736, p = 0.008), glucose concentration (r = − 0.723, p = 0.009), HOMA
index (r = − 0.713, p = 0.010), OGTT results (r = − 0.729, p = 0.008), TC concentration (r = − 0.863, p = 0.001) and
HDLC concentration (r = 0.873, p < 0.001) (Table 3, Fig. 2). These results support the hypothesis and suggest that
the greater training effects of DSW than ASW were associated with greater changes in plasma C1q, apelin and
adropin concentrations between the baseline and post-training time points.
Watanabe and c olleagues13 reported a 39% decrease in the serum C1q concentration in older adults after
12 weeks of bilateral resistance training of the knee flexors and extensors three times a week, which increased
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Figure 2.  Scatter plot graphs for some selected strong correlations in Table 1. Partial correlations between
complement component 1q (C1q) concentration and the maximal voluntary isometric contraction strength of
the knee extensors (∆MVIC) (a), upper thigh circumference (∆CIR) (b), apelin concentration and systolic blood
pressure (∆SBP) (c), diastolic blood pressure (∆DBP) (d), adropin concentration and oral glucose tolerance test
(∆OGTT) results (e), and high-density lipoprotein cholesterols concentration (∆HDLC) (f) for the participants
in the descending stair walking (DSW) group (n = 15).

the MVIC strength of the muscles by 8–12% and the muscle cross-sectional area by 7%. The researchers stated
that C1q was a novel biomarker of s arcopenia13, and a potential role for C1q concentration in the development
of collagen in bones has been reported20. In the present study, 12 weeks of DSW training decreased the plasma
C1q concentration by 51% (Fig. 1a) and increased MVIC strength and BMD by 34% and 6%, respectively. It is
interesting that the magnitude of decrease in the C1q concentration in the blood and increase in muscle strength
and BMD seemed to be greater after DSW than after resistance training in the aforementioned study13, in which
the intensity of eccentric contractions performed in the resistance training protocol was likely to be higher than
that in the DSW training protocol. However, the total number of eccentric contractions performed by each
leg during the training period was much greater in the DSW training protocol than in the resistance training
protocol. It may be that not only the intensity but also the number of eccentric contractions causes the decrease
in the C1q concentration in the blood after DSW training. Since the same number of concentric contractions
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performed in the ASW training protocol did not decrease the plasma C1q concentration, it seems likely that
eccentric contractions were responsible for the decrease in the plasma C1q concentration in the present study.
The magnitude of the increase in the plasma apelin concentration after DSW was 23% (Fig. 1b). A previous
study reported a significant decrease in the apelin concentration (− 30%) after 8 weeks of aerobic exercise training
[50–70% of the maximal heart rate (HRmax)] in obese adult women21; however, other studies16,17,22 have shown
significant increases in apelin concentration after aerobic exercise training. For example, Fujie and colleagues22
reported a 117% increase in the plasma apelin concentration after aerobic exercise training at 60–70% of the
VO2 peak three times a week for 8 weeks in middle-aged and older adults. Kadoglou and c olleagues16 found a
39% increase in the serum apelin concentration after 12 weeks of aerobic exercise training four times a week for
45–60 min per session in patients with T2DM. Afshounpour and c olleagues17 also reported that a combination
of aerobic (50–75% of the maximal heart rate) and whole-body resistance exercise training (30–75% of 1-RM)
increased the plasma apelin concentration by 29% in patients with T2DM. Thus, the magnitude of the increase
in the plasma apelin concentration observed in the present study after DSW was comparable to that reported
by Afshounpour and colleagues17. It appears that metabolic demand during exercise is a factor affecting the
increase in the apelin concentration in the blood. However, no increase in the plasma apelin concentration
was evident after ASW, during which the HR was higher (114 bpm: ~ 74% of the H
 Rmax) than that during DSW
(89 bpm: ~ 58% of the HRmax). It may be that the intensity of ASW was too low to increase the plasma apelin
concentration. It seems possible that eccentric contractions contribute to the increase in apelin concentration
in the blood, probably through a different mechanism than aerobic factors. Apelin is involved in the regulation
of eNOS gene expression and contributes to NO production in the endothelial cells of the aorta23,24. It would be
interesting to investigate changes in NO concentration after DSW in comparison to after ASW or other modes
of eccentric exercises.
Regarding the plasma adropin concentration, the magnitude of increase was 127% after DSW, but the increase
was not significant after ASW (Fig. 1c). It appears that the extent of the increase after the 12-week DSW intervention was greater than that reported in previous studies19,25. Fujie and colleagues19 showed an 80% increase in
the serum adropin concentration after 8 weeks of aerobic cycling training in middle-aged and older individuals. In contrast, two previous studies reported no significant increases in serum adropin concentrations after
acute26,27 and chronic aerobic exercise in healthy young men and middle-aged individuals, respectively. Zhang
and colleagues25 stated that serum adropin might underlie the improvement in endothelial function induced by
aerobic exercise. It should be noted that the aerobic component of DSW was minimal, as indicated by the low
HR of the participants during DSW (~ 58% of the HRmax); however, the plasma adropin concentration more
than doubled after DSW intervention, and no such increase was observed after ASW intervention (Fig. 1c). It
is possible that eccentric contractions have a synergistic effect with aerobic exercise in increasing the adropin
concentration in the blood after exercise training.
The magnitude of the decrease in the plasma C1q concentration and increase in the plasma apelin and adropin
concentrations after DSW was strongly (r > 0.7 and p ≤ 0.01) correlated with the changes in some of the outcome
measures (Table 3). A significant (p ≤ 0.01) correlation was found only between the magnitude of change in apelin
concentration and DBP (r = − 0.732), CS (r = − 0.717), and HbA1c levels (r = 0.762) after ASW. After DSW, the
C1q concentration changes were more strongly correlated with muscle and bone markers, the apelin concentration changes were more strongly associated with blood pressure, and the adropin concentration changes were
related to insulin sensitivity and blood lipid profiles (Table 3).
The magnitude of the decrease in the plasma C1q concentration after DSW was strongly (r > 0.7 and p ≤ 0.01)
correlated with the increase in MVIC strength, upper thigh circumference, BMD and 6 MW test results. It appears
that skeletal muscle adaptations were associated with a decrease in the C1q concentration. Previous studies12,13
have reported that C1q expression in the blood is a marker of sarcopenia and that the greater the concentration
of C1q is in the blood, the greater the extent of sarcopenia. Watanabe and c olleagues13 found that the decrease in
the serum C1q concentration after 12 weeks of resistance training was significantly correlated with the increase
in muscle cross sectional area in older adults and stated that the serum C1q concentration reflected the loss of
muscle mass and strength upon ageing and responded to progressive resistance training. It is known that resistance exercise elevates protein synthesis in muscles, activates satellite cells, promotes the cell cycle, and increases
anabolic action28,29. It is possible that DSW induced these changes and increased MVIC and muscle mass along
with decreasing the plasma C1q concentration. Regarding apelin concentration, the magnitude of the increase in
the plasma apelin concentration was highly (r > 0.7 and p ≤ 0.01) correlated with the decreases in resting SBP and
DBP as well as 6 MW test results. Apelin is involved in many physiological processes, including the regulation
of blood pressure and cardiac function15,29. Pang and colleagues30 reported that apelin administration reduced
the systolic pressure of hypertensive rats, and Ishida and colleagues23 showed that the hypotensive effect of
apelin was mediated through the Akt/eNOS pathway. Andersen and c olleagues31 stated that apelin modulated
eNOS expression, induced eNOS-dependent vasodilatation in the systemic and pulmonary circulation, and
counteracted angiotensin-II-induced vasoconstriction. It has been documented that vasodilation mediated by
NO in contracting muscles via increases in NO concentrations decreases blood p
 ressure32. It should be noted
that the plasma apelin concentration did not change after ASW training; however, the HR and SBP were also
decreased significantly after ASW training, although the magnitude of decrease was less than that after DSW
training. It seems possible that apelin was not the only factor contributing to the improvements in HR and SBP
induced by DSW training.
Regarding adropin concentration, the magnitude of changes in the plasma adropin concentration was strongly
(r > 0.7 and p ≤ 0.01) correlated with balance with EOFS, insulin sensitivity (glucose concentration, HOMA index,
OGTT results), and lipid profiles (TC and HDLC concentrations), as shown in Table 3. It is possible that adropin
improved dyslipidaemia, glucose tolerance and insulin resistance through regulation of NO b
 ioavailability33,34.
35
Shahjouei and colleagues showed that adropin promoted glucose oxidation by decreasing the acetylation of
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pyruvate dehydrogenase complex (PDHC), which is a rate-limiting factor for glucose oxidation, and downregulated the expression pyruvate dehydrogenase kinase-4 (PDK-4), which is a PDHC inhibitor. Several studies
have demonstrated the roles of adropin in regulating glucose metabolism36–41. Adropin has also been shown to
regulate fuel selection in skeletal muscle to reduce fat oxidation while enhancing glucose o
 xidation42,43. It may
be that the descending stair walking intervention effects on improving insulin resistance, blood lipid profile, and
cardiovascular health were related to increased blood flow and capillary density associated with the increased
adropin33. It is known that peroxisome proliferator-activated receptor gamma-activating factor 1 alpha (PGC-1α)
affects the activity of carnitine palmitoyltransferase-1 (CPT-1) and PDK-4, which play key roles in the oxidation
of fatty acids and glucose oxidation via the PDK p
 athway44,45. Ghoshal and c olleagues46 reported that the plasma
adropin concentration was inversely related to the plasma LDLC concentration in humans, suggesting a link
with hepatic lipid metabolism. Thus, the large increase in adropin concentration after DSW may suggest that
PGC-1α and its downstream pathways were more activated by DSW than ASW. It has also been documented that
circulating adropin promotes the production of NO and increases NO bioavailability, which improves arterial
stiffness after aerobic exercise training22. However, no significant partial correlations were found between the
increase in adropin concentration and the decrease in SBP in the present study (Table 3).
The mechanisms underlying the greater changes in plasma C1q, apelin and adropin concentrations after
DSW training than after ASW training are not clear, but some speculations can be made. The main difference
between DSW and ASW was the type of muscle contraction performed by the knee extensors; eccentric contractions were mainly performed during DSW, and concentric contractions were performed during ASW7. It has
been shown that eccentric contractions promote the anabolic signalling pathway (elevating protein synthesis
in muscle, increasing the satellite cell number, and promoting the cell cycle) to a greater extent than concentric
contractions47,48. It should be noted that the intensity of eccentric contractions performed during DSW was
lower than the maximal eccentric contraction strength. Samuel and colleagues49 examined biomechanical functional demand placed on the knee and hip muscles of older adults during DSW and ASW and reported that the
functional demand relative to the MVIC strength of the knee extensors was greater during DSW (73%) than
ASW (42%). D’Lima and c olleagues50 reported that the peak force of the knee extensors was 2.8 × body weight
(BW) during walking, 2.8 × BW during ASW, 3.1 × BW during DSW, and 3.6 × BW during jogging. Eccentric
loading during normal walking is approximately 25% of the MVIC strength of the knee extensors51. Thus, the
actual loading to the knee extensors during DSW and ASW does not appear to be largely different, but it seems
possible that the type of muscle contraction of the knee extensors itself (eccentric vs concentric) rather than the
force was the key factor contributing to the different changes in C1q, apelin and adropin concentrations between
the DSW group and ASW group.
Myokines are cytokines and other peptides that are secreted from skeletal muscles, especially in response to
exercise; these peptides function like hormones either locally within the muscle or by targeting distant o
 rgans52.
Apelin is classified as a myokine since it is produced and secreted not only by adipose tissue but also by skeletal
muscle in response to exercise53. Adropin is considered a neuropeptide since energy homeostasis-associated
(ENHO) genes are abundant in the brain, including the ventromedial and lateral hypothalamic nuclei, which
regulate appetite and autonomic function54. Hepatic ENHO expression is associated with the expression of genes
involved in glucose and lipid m
 etabolism54. The present study revealed that apelin and adropin concentrations
increased only after DSW, during which eccentric contractions were mainly performed. Eccentric contractions
can produce high levels of mechanical tension per active motor unit, stretch-induced strain, and a greater propensity for muscle damage than concentric c ontractions55. It may be that eccentric contractions triggered the
secretion of apelin and adropin by imposing greater mechanical stresses on muscle fibres, surrounding connective
tissue, and capillaries and/or blood vessels. Further studies are needed to compare the effects of eccentric and
concentric contractions on the secretion of myokines or neuropeptides.
Ageing is unavoidable, but decreases in physical function upon ageing can be attenuated by performing
regular exercise, which is easier said than done. As the aged population increases worldwide, increasing health
span is critical, and increasing physical activity and exercise is crucial. One of the barriers to physical activity
is a lack of confidence in one’s ability to be physically active (low self-efficacy)56. As shown in the present study,
the beneficial effects of DSW are encouraging to some people who are less fit and less confident in performing
more physically demanding exercises. The significance of eccentric contractions in exercise prescription and the
use of eccentric exercises such as DSW, downhill walking, or sitting to a chair slowly should be more strongly
emphasised.
The present study had several limitations. First, the participants of the study were obese elderly women; thus,
the results of the study may not generalize to young, adult and middle-aged men and women. Second, only
plasma C1q, apelin and adropin concentrations were measured in the present study, and other parameters, such
as well-known exercise-related biomarkers (blood adiponectin and leptin concentrations)57, were not evaluated
in the present study. Third, the total number of participants in each group was 15, which was not appropriate
for multiple regression analysis. It should also be noted that we did not control for the daily physical activity
of the subjects during the experimentation, although we instructed and reminded the participants to maintain
their normal daily lifestyles. Last, the present study was rather descriptive, and a mechanistic investigation of
the factors affecting the changes in C1q, apelin and adropin concentrations following DSW was absent. Future
studies considering these limitations and examining whether myokine and other biomarker responses are different following eccentric and concentric exercise are warranted.
In conclusion, the present study showed that the magnitude of changes in plasma C1q, apelin and adropin
concentrations between pre- to post-training time points was greater in the DSW group than in the ASW group.
It appears that the decrease in the plasma C1q concentration was more strongly associated with the increase
in muscle and physical functions, that the increases in plasma apelin and adropin concentrations were more
strongly associated with improvements in insulin sensitivity and lipid profiles, and that the increase in the
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plasma apelin concentration was also associated with decreases in the resting HR and blood pressure as well as
musculoskeletal and fitness. Further studies are required to investigate how greater changes in C1q, apelin and
adropin concentration are induced by DSW intervention than by ASW intervention using a larger sample size.

Methods

Participants. We conducted secondary analyses of muscular, physical fitness, bone, cardiovascular, insulin
sensitivity and lipid profile data from the previous intervention study in which older obese women performed
descending (DSW) or ascending stair walking (ASW) training twice a week for 12 weeks. Thirty obese (body
fat ≥ 30%) older (60–82 years old) women who had been sedentary provided informed consent to participate in
the study, which was approved by the Joint Institutional Review Board of Taipei Medical University (approval
#: 201502034). The participants were recruited from several Taipei City District health centres (Heihu, Shilin,
Beitou). Their eligibility and suitability to participate in the study was determined by the International Physical
Activity Questionnaire (IPAQ) and a health and medical questionnaire. An experienced orthopaedist checked
the participant’s lower extremities to ensure that the participants had no knee or ankle problems, degenerative
joint and muscle disease, or osteoarthritis that might be exacerbated by stair walking exercise. The participants
were quasi-randomly divided into the DSW and ASW intervention groups (n = 15 per group) so that the average
baseline MVIC strength of the knee extensors, age, body mass, and percent body fat were similar between the
groups7. Briefly, a maximum of eight participants were recruited at the same time, and they were ranked based
on the MVIC strength, placed into one of the two groups by a lottery from the top pair to the bottom pair, to
ensure that the baseline of MVIC strength was similar between the DSW and ASW groups. The sample size was
estimated on the basis of an effect size of 1.0, an α-level of 0.05, and a power (1-β) of 0.80 for the possible difference in the increase in the MVIC strength of the knee extensors between the groups based on our pilot study
using G*Power (G*Power 3.1.9.2; Heinrich-Heine-Universitat Dusseldorf, Dusseldorf, Germany). According
to the analysis, 14 participants per group were necessary. Considering the possibility of participant dropout,
15 participants per group were recruited. No significant differences in any of the physiological characteristics
were observed between the DSW (mean ± standard deviation (SD): age, 65.4 ± 6.6 y; height, 154.9 ± 5.5 cm; body
mass, 62.8 ± 5.1 kg; body mass index (BMI), 26.2 ± 1.1; percent body fat, 36.4 ± 3.3%) and ASW (age, 67.5 ± 7.1 y;
height, 155.6 ± 6.2 cm; body mass, 62.7 ± 6.4 kg; BMI, 26.1 ± 0.8; percent body fat, 34.6 ± 5.3%) groups at baseline.
Exercise intervention. The exercise intervention was described in a previous s tudy7. Briefly, all partici-

pants performed progressive exercise training on the stairs of a 10-story building twice a week for 12 weeks7. An
elevator was used to take the participants in the DSW group from the first to sixth floor and to take those in the
ASW group from the sixth to first floor. Thus, the DSW group did not walk up stairs, and the ASW group did not
walk down stairs during the exercise intervention. The number of stairs from the first to the sixth floor was 110
(five floors, 22 stairs per floor). The walking tempo was approximately 1 s per step; thus, to descend or ascend 110
stairs, it took approximately 2 min. The exercise volume was gradually increased for both groups over 12 weeks
by increasing the number of repetitions by two every week (i.e., first week, 2 repetitions per session; 12th week,
24 repetitions per session)7. It took approximately 5 min to perform two repetitions, including the time waiting
for and riding on the elevator, and the time taken to perform 24 repetitions was approximately 60 min, including approximately 12 min waiting for the elevator or in the elevator. Thus, the intervention was an intermittent
exercise during which an approximately 2-min walk followed by a 30-s rest was repeated.
During stair walking, HR was recorded with a Polar RS800CXN monitor (Polar Electro, Kempele, Finland),
and SBP and DBP were measured using an automated sphygmomanometer (MS 150f., Rossmax International
Ltd., Taipei, Taiwan) before, during (HR only) and immediately after each s ession7,58.

Outcome measures. The participants were familiarised with the testing procedures a week before the first
exercise session. The details of the familiarisation session and criterion measures were reported in a study by
Chen and colleagues7. Briefly, the criterion measures were height, body mass, percent body fat, resting HR, SBP,
DBP, upper thigh circumference; right calcaneus bone mineral density (BMD), MVIC strength of the right knee
extensors, performance in functional fitness tests for senior adults, including the 30-s chair stand (CS), 2-min
step (2MS), 6-m walk (6 MW) and 6-m tandem walk (TW), and balance (balance with EOFS and ECUS) tests;
levels of insulin sensitivity markers (resting glucose and insulin concentrations, HOMA index, HbA1c concentration, OGTT results) and blood lipid profiles (TG, TC, HDLC, and LDLC concentrations)7,59.
The participants rested in the supine position for at least 10 min before measurement of HR, SBP, and DBP,
and the measurements were taken while the participants were lying supine on a padded table. The calcaneal BMD
of the right heel of each participant was assessed using a bone sonometer (CM-100; Furuno Electric Co., Hyogo,
Japan). Speed of sound (m/s) was used as a quantitative ultrasound parameter determined by the width of the
heel and time delay between initial transmission and subsequent receipt of sound w
 aves7,60.
Assessment of MVIC strength of the knee e xtensors56,60–62; functional physical fitness tests for senior adults,
i.e., the CS, 2MS, 6 MW, TW; and two balance tests (balance with EOFS and ECUS), which were carried out using
a Biodex BioSway Portable Balance System (Model 950-460; Biodex Medical Systems, Shirley, NY, USA), were
performed 3 days before the first training session to obtain baseline measures and 4 days after the last training
session to evaluate the effects of the t raining7. Resting HR, blood pressure, and upper thigh circumference were
also measured at these time points7.
Approximately 10 ml of blood and another 3 ml of blood for measuring HbA1c concentration were drawn
from the cubital fossa region of the arm by the same standard venipuncture technique 3 days before the first
training session and 4 days after the last training s ession7. Five millilitres of venous blood (10 ml) was put in
a vacutainer tube containing dipotassium ethylenediaminetetraacetic acid (Becton Dickinson and Company,
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Plymouth, UK), and another 5 mL of blood was left in the original vacutainer tube with a serum separator and
clotting activator (silica) (Becton Dickinson and Company, Plymouth, UK) for 30 min at room temperature
and centrifuged (2000 rpm) for 10 min to obtain plasma and serum, respectively. Serum samples were used for
insulin sensitivity measures (i.e., resting glucose and insulin concentrations, HOMA index, HbA1c concentration) and lipid profiles (serum TG, TC, LDLC and HDLC concentrations). The remaining plasma samples were
stored at − 80 °C for analyses of C1q, apelin and adropin concentrations. For the OGTT, capillary blood samples
were obtained from the fingertips of each participant using sterilised Softclix lancets (Roche Diabetes Care Ltd.,
Surrey England, UK) before and 30, 60, 90 and 120 min after consumption of a 75-g standard glucose drink,
and blood glucose concentrations were measured with an analyser (Johnson & Johnson, Livingstone, Scotland,
UK). The detailed procedures used for analyses of glucose, insulin, OGTT, HbA1c, HOMA, TG, TC, LDLC, and
HDLC were described previously7,63–65.

C1q, apelin and adropin concentrations. Plasma C1q, apelin and adropin concentrations were measured by enzyme-linked immunosorbent assay (ELISA) using commercially available kits [C1q: Human C1q
ELISA Kit, GA-E0374HM, GenAsia Biotech Co., Ltd, Shanghai, China; apelin: Human AP12 ELISA Kit, GAE0024HM, GenAsia Biotech Co., Ltd, Shanghai, China; adropin: Human Adropin (ENHO) ELISA Kit, CSBEL007669HU, CUSABIO®, Wuhan, China] according to the instructions of the manufacturer. The detection
limits of the plasma C1q, apelin and adropin assays were 0.156–10 ng/ml, 31.25–2,000 pg/ml and 1.56–100 pg/
ml, respectively. The reliability of the plasma C1q, apelin and adropin concentrations was checked by the coefficient of variation (CV) and intraclass correlation (r), which were 3.9% (r = 0.953), 9.2% (r = 0.950) and 9.7%
(r = 0.900) for plasma C1q, apelin and adropin, respectively.
Statistical analyses. The data were assessed by the Shapiro–Wilk test for normality and by the Levene test

for the homogeneity of variance assumption. These tests showed that the data for all parameters were normally
distributed, and the variance was assumed to be homogenous. The baseline values of all dependent variables
before DSW and ASW training exercise bouts were compared by t-tests. Changes in the all measures and plasma
C1q, apelin and adropin concentrations over time were compared between the DSW and ASW groups by mixedmodel two-way analysis of variance (ANOVA). When a significant interaction effect was found, Tukey’s post
hoc test was performed. η2 was calculated as a measure of effect size and was classified as follows: ~ 0.02: small
effect; ~ 0.13: medium effect; and > 0.26: large e ffect66. The significance level was set at p ≤ 0.05 for all dependent
variables. Partial correlation analyses controlling for possible confounding factors (age, height, body mass, BMI,
and percent body fat) were used to assess the relationships between C1q, apelin or adropin concentrations and
all other variables in the DSW and ASW groups. The significance level was set at p ≤ 0.01 for multiple partial
correlation analyses based on the small sample size (n = 15) for each group67. The data are presented as the
mean ± SD.

Ethical statement. All methods in the study complied with the current guidelines, regulations and laws of
Taiwan where the study was performed in accordance with the 1964 Helsinki declaration.
Ethical approval.

All experimental protocols were approved by the Joint Institutional Review Board of
Taipei Medical University (approval #: 201502034).

Informed consent document. A written informed consent was obtained from each participant of the
study.

Data availability

All data generated or analysed during this study are included in this submitted manuscript, and the data of the
current study are available from the corresponding author on reasonable request.
Received: 19 June 2020; Accepted: 6 August 2021
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